Biomarker Testing Market Report Evaluates Growth Drivers, Challenges And Market Dynamics

The biomarker testing market is on a significant growth trajectory, driven by advancements in medical technology and a growing emphasis on personalized healthcare. As the healthcare industry evolves, the demand for precise, early diagnostics and tailored treatment strategies is propelling this market forward. Let's explore the current market size, key players, emerging trends, and segmentations shaping the future of biomarker testing.

Projected Expansion of the Biomarker Testing Market by 2030
The biomarker testing market is projected to experience substantial growth, reaching a market value of $35.51 billion by 2030. This corresponds to a robust compound annual growth rate (CAGR) of 12.4% during the forecast period. Factors contributing to this surge include increased investments in personalized medicine, a wider application of biomarkers in drug development, and the growth of oncology and infectious disease testing. Additionally, the rising preference for minimally invasive diagnostic methods and advancements in multi-omics technologies are further propelling market expansion. Notable trends expected to influence the market include the growing adoption of precision medicine diagnostics, enhanced use of companion diagnostics, integration of artificial intelligence (AI) in biomarker analysis, expansion in liquid biopsy testing, and an intensified focus on early disease detection.

The biomarker testing market size has grown rapidly in recent years. It will grow from $19.75 billion in 2025 to $22.26 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, expansion of clinical research activities, rising adoption of molecular diagnostics, growing demand for targeted therapies, availability of advanced testing platforms.

Download a free sample of the biomarker testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24480&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Corporations Driving the Biomarker Testing Market
The biomarker testing landscape features several prominent companies shaping its direction. Key players include Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton dic*kinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., and Proteome Sciences plc.

Notably, in August 2025, Quanterix Corp., a US-based life sciences firm, acquired Emission Inc. for about $70 million. This strategic acquisition aims to broaden Quanterix's technology offerings and market presence by incorporating Emission's advanced multiplex and multi-omic assay technologies. This move is expected to enhance Quanterix's diagnostic capabilities and open new growth avenues within the biomarker testing sector. Emission Inc., also based in the US, specializes in providing multiplex and multi-omic assay solutions tailored for biomarker testing.

View the full biomarker testing market report:
https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Technological Innovations Steering the Biomarker Testing Industry
Cutting-edge developments are at the heart of progress in the biomarker testing market. Many leading companies focus on advancing immunohistochemistry (IHC) technology, which significantly improves diagnostic precision, facilitates early disease detection, and supports personalized treatment approaches. This laboratory technique uses antibodies to detect specific proteins in tissue samples, helping identify biomarkers crucial for disease diagnosis and research.

For example, in July 2023, Quest Diagnostics Incorporated, a US medical laboratory services provider, launched a new tissue-based prostate cancer biomarker test through its AmeriPath division. This test utilizes proprietary biomarkers EV1, EV2, and EV3 to enhance diagnostic accuracy. It addresses a vital clinical need by enabling physicians to more accurately distinguish aggressive prostate cancer forms, improving grading consistency, and guiding more effective treatment decisions.

Detailed Market Segmentation and Forecasts in Biomarker Testing
The biomarker testing market is divided into several key segments for a comprehensive understanding:

1) Product Type: Consumables, Instruments, and Services
2) Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunoassays, and Other Technologies
3) Application: Oncology, Cardiology, Neurology, Infectious Diseases, and Other Applications
4) End-User: Hospitals, Diagnostic Laboratories, Research Institutes, and Other End-Users

Further subcategories break down as follows:
- Consumables include reagents, assay kits, sample collection devices, and chemicals and buffers.
- Instruments cover PCR systems, NGS platforms, microarray systems, mass spectrometry instruments, and immunoassay analyzers.
- Services encompass biomarker discovery services, diagnostic testing, companion diagnostic development, clinical trial testing, and contract research organization (CRO) services.

By analyzing these segments, stakeholders can gain insight into market dynamics and areas with the highest growth potential.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.